Health
Oxford Coronavirus vaccine update: Phase III trials to conclude by November, mass production expected by 2021 – Times of India
Oxford University backed vaccine is currently in its last stage of testing. The news follows after Russia successfully registered the world’s first COVID-19 vaccine, ‘Sputnik V’ after claiming decent results post completion of phase I.
The announcement also comes after SII head, Adar Poonawallah announced the availability of the vaccine for Indian masses by 2020. In an interview with a media agency recently, he spoke at length, saying:
“We are going to start trials in less than two weeks. The trial is in partnership with ICMR. We will start manufacturing vaccines by the end of August.”
According to revised proposals, the vaccine under the offering, which will be sold and marketed as ‘Covishield’ in India, will involve candid…
-
Noosa News7 hours agoBrisbane man Benjamin Holt speaks out about teen who allegedly organised Airbnb party that led to his house being trashed
-
Business5 hours agoSoaring one day, plunging the next. Why is the ASX 200 on a rollercoaster?
-
Business12 hours agoHow I’d build a $100,000 ASX portfolio from scratch
-
Noosa News19 hours agoGold Coast father speaks out after he and his son were shot and stabbed in Surfers